ANTAGONISTE ZUR BEHANDLUNG VON CD11/CD18 ADHÄSIONSREZEPTOR-VERMITTELTEN KRANKHEITEN

Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MCDOWELL, ROBERT S, MARSTERS, JAMES C, OARE, DAVID, WEESE, KENNETH J, GADEK, THOMAS R, BURDICK, DANIEL, J, STANLEY, MARK S, REYNOLDS, MARK
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.